Results 61 to 70 of about 1,874,188 (207)

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults.

PLoS Neglected Tropical Diseases, 2016
BackgroundThe bivalent whole-cell (BivWC) oral cholera vaccine (Shanchol) is effective in preventing cholera. However, evaluations of immune responses following vaccination with BivWC have been limited.
Wilfredo R Matias, Brie Falkard, Richelle C Charles, Leslie M Mayo-Smith, Jessica E Teng, Peng Xu, Pavol Kováč, Edward T Ryan, Firdausi Qadri, Molly F Franke, Louise C Ivers, Jason B Harris   +11 more
doaj   +1 more source

Nanomaterial Strategies for Pulmonary Delivery of Immunotherapeutics in Lung Cancer Treatment

Advanced Healthcare Materials, Volume 15, Issue 34, 11 September 2026.
Inhalable immunotherapeutic nanomedicines enable organ‐selective immune modulation by overcoming pulmonary delivery barriers and concentrating therapy within lung tumors. This Review defines how nanomaterial properties govern airway deposition, retention, cellular partitioning, and immune activation across vaccines, checkpoint blockade, STING agonists,
Han Zhang, Wei Tang
wiley   +1 more source

The case for ring vaccinations with special consideration of oral cholera vaccines [PDF]

Human Vaccines & Immunotherapeutics, 2018
Ring vaccinations create a zone of immune contacts around a case to prevent further disease transmission and have been successfully employed in the eradication of smallpox and the control of other infections. Millions of oral cholera vaccine (OCV) doses have been effectively deployed through mass vaccination campaigns. But there are situations when the
Deen, J, Von Seidlein, L
openaire   +4 more sources

The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan. [PDF]

, 2015
The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South ...
John Rumunu (257691), Abubakar, A, Rumunu, J, Abdinasir Abubakar, William Perea (371833), Ciglenecki, I, West, H, Iza Ciglenecki (446458), Justin Lessler, Helderman, T, Legros, D, Stephen Martin, Abdinasir Abubakar (544016), Sack, D.A, Francisco J Luquero, Andrew S Azman, Dominique Legros, Dominique Legros (267127), Haley West (828581), Francisco J. Luquero (121649), David A. Sack (219219), Perea, W, Stephen Martin (483345), Lessler, J, William Perea, Luquero, F.J, Iza Ciglenecki, David A Sack, Haley West, Justin Lessler (116180), John Rumunu, Trina Helderman, Andrew S. Azman (121645), Azman, A.S, Martin, S, Trina Helderman (828580), Abubakar Abdinasir, Luquero Francisco J., Ciglenecki Iza, Helderman Trina, Lessler Justin, Rumunu John, Perea William, Legros Dominique, West Haley, Sack David A., Azman Andrew S., Martin Stephen   +47 more
core   +1 more source

Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.

PLoS Neglected Tropical Diseases, 2019
The bivalent killed whole-cell oral cholera vaccine (BivWC) is being increasingly used to prevent cholera. The presence of O-antigen-specific memory B cells (MBC) has been associated with protective immunity against cholera, yet MBC responses have not ...
Brie Falkard, Richelle C Charles, Wilfredo R Matias, Leslie M Mayo-Smith, J Gregory Jerome, Evan S Offord, Peng Xu, Pavol Kováč, Edward T Ryan, Firdausi Qadri, Molly F Franke, Louise C Ivers, Jason B Harris   +12 more
doaj   +1 more source

High Awareness, Poor Practice: The Cholera Prevention Knowledge‐Attitude‐Practice Gap in Ada Foah, Ghana—A Cross‐Sectional Study

Public Health Challenges, Volume 5, Issue 3, September 2026.
ABSTRACT Background Cholera persists as a public health threat in Ghana, particularly in coastal communities with inadequate water, sanitation and hygiene (WASH) infrastructure. This study assessed the knowledge, attitudes and practices (KAP) toward cholera among residents of Ada Foah, a high‐risk coastal district in Ghana, to identify gaps and inform ...
Christopher Yaw Dumevi, Princess Afia Takyiwaa Dwomoh, Hugette Naa Ayeley Aryee, Joyce Junior Asiamah, Gifty Selorm Amenya, Gloria Amoo Aidoo, Dorcas Akuokor Teiko, Isaac Ekow Ennin, Eric Essandoh Amuah, James‐Paul Kretchy, Saviour Kweku Adjenti, Patrick F. Ayeh‐Kumi   +11 more
wiley   +1 more source

Immuno‐Informatics Design of Multi‐Epitope Vaccine Candidate Against Anaplasma phagocytophilum Using Major Surface Protein 4 (MSP‐4) Antigen

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Bovine anaplasmosis is an intracellular tick‐borne, non‐contagious disease caused by gram‐negative bacteria of the family Anaplasmataceae and order Rickettsia. Anaplasma phagocytophilum is the etiological agent for human granulocytic anaplasmosis associated with severe health implications in parts of Europe and the USA and ...
Samson Anjikwi Malgwi, Sinalo Mani, Iliya Dauda Kwoji, Victoria T. Adeleke, Matthew A. Adeleke, Moses Okpeku   +5 more
wiley   +1 more source

History of the development of oral cholera vaccine in Vietnam.

, 2014
History of the development of oral cholera vaccine in Vietnam.
Dang Duc Anh (232106), Jacqueline L. Deen (148731), Anna Lena Lopez (92298), Vu Dinh Thiem (232108), Hung Thi Mai Tran (624674), Nguyen Van Cuong (624675), Lorenz von Seidlein (45473), David A. Sack (219219), Mohammad Ali (73095)   +8 more
core   +1 more source

Efficacy and Safety of Cholera Vaccines

Биопрепараты: Профилактика, диагностика, лечение, 2018
Cholera is an acute diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and O139 serogroups. It still remains a major  global healthcare problem.
A. A. Goryaev, L. V. Sayapina, Yu. I. Obukhov, V. P. Bondarev   +3 more
doaj   +1 more source